Literature DB >> 11358473

Is methicillin-resistant Staphylococcus aureus (MRSA) contamination of ward-based computer terminals a surrogate marker for nosocomial MRSA transmission and handwashing compliance?

J Devine1, R P Cooke, E P Wright.   

Abstract

A survey of two acute district general hospitals (A and B) was undertaken to investigate the extent of methicillin-resistant Staphylococcus aureus (MRSA) contamination of ward-based computer terminals. Of 25 terminals examined, MRSA was identified in six (24%). Environmental contamination was of a low level. Five of the MRSA positive terminals were from hospital A which had a significantly higher rate of MRSA transmission compared to hospital B (1.02 vs. 0.49 new inpatient MRSA cases per 100 hospital admissions for 1999). MRSA containment and handwashing policies were similar at both hospitals, though only hospital B actively audited handwashing compliance and had a 44% higher rate of paper towel usage per hospital bed. Ward-based computer terminals pose a low risk of MRSA cross-infection. This risk can be further reduced if all staff wash their hands before and after patient contact. Copyright 2001 The Hospital Infection Society.

Entities:  

Mesh:

Year:  2001        PMID: 11358473     DOI: 10.1053/jhin.2001.0955

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  15 in total

1.  Community-associated methicillin-resistant Staphylococcus aureus skin infections in a religious community.

Authors:  F Coronado; J A Nicholas; B J Wallace; D J Kohlerschmidt; K Musser; D J Schoonmaker-Bopp; S M Zimmerman; A R Boller; D B Jernigan; M A Kacica
Journal:  Epidemiol Infect       Date:  2006-07-26       Impact factor: 2.451

2.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

Review 3.  MRSA and the environment: implications for comprehensive control measures.

Authors:  N Cimolai
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-02-14       Impact factor: 3.267

Review 4.  Gloves, gowns and masks for reducing the transmission of meticillin-resistant Staphylococcus aureus (MRSA) in the hospital setting.

Authors:  Jesús López-Alcalde; Marta Mateos-Mazón; Marcela Guevara; Lucieni O Conterno; Ivan Solà; Sheila Cabir Nunes; Xavier Bonfill Cosp
Journal:  Cochrane Database Syst Rev       Date:  2015-07-16

5.  Screening and characterization of Staphylococcus aureus from ophthalmology clinic surfaces: a proposed surveillance tool.

Authors:  Rachel E Reem; Joany Van Balen; Armando E Hoet; Colleen M Cebulla
Journal:  Am J Ophthalmol       Date:  2014-01-09       Impact factor: 5.258

6.  A prospective study of the case-notes of MRSA-positive patients: a vehicle of MRSA spread.

Authors:  N Hamza; G Bazoua; Y Al-Shajerie; E Kubiak; P James; C Wong
Journal:  Ann R Coll Surg Engl       Date:  2007-10       Impact factor: 1.891

7.  Methicillin-resistant Staphylococcus aureus infections of the eye and orbit (an American Ophthalmological Society thesis).

Authors:  Preston Howard Blomquist
Journal:  Trans Am Ophthalmol Soc       Date:  2006

Review 8.  Basic microbiologic and infection control information to reduce the potential transmission of pathogens to patients via computer hardware.

Authors:  Alice N Neely; Dean F Sittig
Journal:  J Am Med Inform Assoc       Date:  2002 Sep-Oct       Impact factor: 4.497

9.  Two cases of corneal ulcer due to methicillin-resistant Staphylococcus aureus in high risk groups.

Authors:  Kyung-Min Lee; Hyun-Soo Lee; Man-Soo Kim
Journal:  Korean J Ophthalmol       Date:  2010-08-03

10.  Computer keyboard and mouse as a reservoir of pathogens in an intensive care unit.

Authors:  Bernd Hartmann; Matthias Benson; Axel Junger; Lorenzo Quinzio; Rainer Röhrig; Bernhard Fengler; Udo W Färber; Burkhard Wille; Gunter Hempelmann
Journal:  J Clin Monit Comput       Date:  2004-02       Impact factor: 2.502

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.